Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2964]

FDA approves pembrolizumab or pembrolizumab and berahyaluronidase alfa-pmph each with enfortumab vedotin-ejfv for muscle invasive bladder cancer

FDA approves pembrolizumab or pembrolizumab and berahyaluronidase alfa-pmph each with enfortumab vedotin-ejfv for...

New experimental approach may help overcome drug resistance in deadly brain cancer

New experimental approach may help overcome drug resistance in deadly brain cancer

Hidden metastases reveal clues to colorectal cancer recurrence

Hidden metastases reveal clues to colorectal cancer recurrence

Young women diagnosed with breast cancer within three years of childbirth may face more aggressive disease

Young women diagnosed with breast cancer within three years of childbirth may face more aggressive disease

Common thyroid hormone may help prevent brain tumour relapse in children, says study

Common thyroid hormone may help prevent brain tumour relapse in children, says study

B-cell lymphoma: Cause of high-risk disease discovered

B-cell lymphoma: Cause of high-risk disease discovered

ESMO GI 2026: Blood test may help identify which colorectal cancer patients with liver metastases are most likely to benefit from chemotherapy after surgery

ESMO GI 2026: Blood test may help identify which colorectal cancer patients with liver metastases are most likely...

New targeted therapy shows promising early results in advanced pancreatic cancer

New targeted therapy shows promising early results in advanced pancreatic cancer

A new approach in cancer medicine: development of a novel “degraders” for the selective elimination of cancer cells

A new approach in cancer medicine: development of a novel “degraders” for the selective elimination of cancer cells

Researchers' new approach boosts immune response against lung cancer

Researchers' new approach boosts immune response against lung cancer

More from ecancer